Candel Therapeutics, Inc. CADL Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s change in AP?
- Candel Therapeutics, Inc. (CADL) reported change in AP of $1.7M in Q1 2026.
- How has Candel Therapeutics, Inc.'s change in AP changed year-over-year?
- Candel Therapeutics, Inc.'s change in AP increased by 234.9% year-over-year, from $507K to $1.7M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.